Eric Novik, Ph.D.
Chief Scientific Officer
Dr. Eric Novik manages HµREL’s R&D and production functions, and he also serves as the Company’s principal technical liaison to scientists in HµREL’s client organizations. He has played a central role in the development and characterization of HµREL’s Hµrelhuman™ and eight other pre-clinical species co-cultures, and also of the Hµrelflow™ multi-tissue microfluidic platform, of all of which he is an inventor. Dr. Novik holds a Ph.D. in biomedical engineering from Rutgers University.